AIMS Pharma Digital Health Care Innovation

Millions of cancer patients across Africa are unable to access life-saving innovative therapies because eligible patients are often not identified, biomarker testing is limited, and pharmaceutical companies lack visibility into real-world demand. AIMS Pharma is building a digital precision oncology platform that connects patients, oncologists, laboratories, and pharmaceutical partners to close these gaps. Through a pilot in Rwanda, Tunisia, and Morocco, we will test how demand mapping, biomarker testing, and treatment-access coordination can improve access to appropriate cancer care. DIV funding will support platform deployment, partnership development, pilot implementation, and evaluation of adoption, feasibility, costs, and patient access outcomes to prepare for scale across Africa.